AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 145 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $29,971,000 | -12.2% | 1,872,070 | -2.0% | 0.04% | -18.2% |
| Q1 2021 | $34,133,000 | +31.8% | 1,910,100 | -0.3% | 0.04% | +29.4% |
| Q4 2020 | $25,888,000 | +14.1% | 1,916,243 | -0.6% | 0.03% | +3.0% |
| Q3 2020 | $22,683,000 | +30.0% | 1,927,191 | +63.1% | 0.03% | +17.9% |
| Q2 2020 | $17,443,000 | -23.7% | 1,181,778 | +218.4% | 0.03% | -37.8% |
| Q3 2018 | $22,848,000 | +11.5% | 371,215 | +22.4% | 0.04% | +9.8% |
| Q2 2018 | $20,491,000 | +41.1% | 303,344 | +13.3% | 0.04% | +32.3% |
| Q1 2018 | $14,521,000 | -12.2% | 267,672 | -3.3% | 0.03% | -8.8% |
| Q4 2017 | $16,535,000 | +22.3% | 276,730 | -0.5% | 0.03% | +17.2% |
| Q3 2017 | $13,521,000 | – | 278,209 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |